Effect of a glucagon-like peptide 1 (GLP-1) receptor agonist, liraglutide, on cognition and body weight during antipsychotic treatment

被引:0
|
作者
Babic, I [1 ,2 ,3 ]
Gorak, A. [1 ,2 ]
Hughes, J. [2 ]
Engel, M. [2 ]
Sellers, D. [1 ,2 ]
Else, P. [2 ]
Lufe, L. [1 ,2 ]
Obeid, A. L. [1 ,2 ]
Osborne, A. L. [1 ,2 ]
Le Mesurier, P. [1 ,2 ]
Pai, N. [2 ,3 ]
Huang, X. F. [1 ,2 ]
Weston-Green, K. [1 ,2 ]
机构
[1] Univ Wollongong, Ctr Translat Neurosci, Wollongong, NSW 2522, Australia
[2] Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia
[3] Illawarra Shoalhaven Local Hlth Dist, Wollongong, NSW 2500, Australia
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PM426
引用
收藏
页码:204 / 204
页数:1
相关论文
共 50 条
  • [21] Splenic Artery Thrombosis and Glucagon-like Peptide-1 (GLP-1) Agonist: Is There an Association?
    Lee, Regis
    Alukal, Joseph J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2966 - S2967
  • [22] Glucagon-like peptide-1 (GLP-1) agonist use and weight change among patients with breast cancer
    Shen, Sherry
    Liu, Bethina
    Fanti, Chad
    Bromberg, Maria
    Chen, Yuan
    Chang, Cassandra
    Iyengar, Neil M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Liraglutide, GLP-1 receptor agonist, for chronic weight loss
    Moore, Katherine G.
    Shealy, Kayce
    Clements, Jennifer N.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (05) : 373 - 378
  • [24] Effects of tryptophan-selective lipidated glucagon-like peptide 1 (GLP-1) peptides on the GLP-1 receptor
    Lu, Xuejing
    Harada, Norio
    Yasuda, Takuma
    Ikeguchi-Ogura, Eri
    Kobayashi, Daishiro
    Denda, Masaya
    Seno, Yohei
    Yamane, Shunsuke
    Yabe, Daisuke
    Otaka, Akira
    Inagaki, Nobuya
    JOURNAL OF ENDOCRINOLOGY, 2025, 264 (03)
  • [25] Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
    Ja'arah, Daria
    Al Zoubi, Mazhar Salim
    Abdelhady, Gamal
    Rabi, Firas
    Tambuwala, Murtaza M.
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2021, 14
  • [26] The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide
    Jennings, L.
    Nestor, L.
    Molloy, O.
    Hughes, R.
    Moriarty, B.
    Kirby, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (03) : 858 - 859
  • [27] Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders
    Wroge, Jamie
    Williams, Nancy Toedter
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (12) : 1041 - 1050
  • [28] Insulin and glucagon-like peptide receptor agonist (GLP 1 RA) combinations
    Kalra, Sanjay
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2014, 64 (03) : 359 - 361
  • [29] Glucagon-like peptide-1 (GLP-1) receptor agonists for weight management: A review for the gynecologic oncologist
    Riedinger, Courtney J.
    Sakach, Julia
    Maples, Jill M.
    Fulton, Jessica
    Chippior, Jessica
    O'Donnell, Benjamin
    O'Malley, David M.
    Chambers, Laura M.
    GYNECOLOGIC ONCOLOGY, 2024, 190 : 1 - 10
  • [30] Multiple Sclerosis Patients on Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss
    Udawatta, Methma
    Mateen, Farrah
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 840 - 840